TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development13,54228,53335,50418,617
Selling General and Administrative7,94910,43612,6589,039
Non Recurring----
Others----
Total Operating Expenses21,49138,96948,16227,656
Operating Income or Loss-21,491-38,969-48,162-27,656
Income from Continuing Operations
Total Other Income/Expenses Net36812710840
Earnings Before Interest and Taxes-21,491-38,969-48,162-27,656
Interest Expense----
Income Before Tax-21,123-38,842-48,054-27,616
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-21,123-38,842-48,054-27,616
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,123-38,842-48,054-27,616
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,123-38,842-48,054-27,616